Avantor Inc.. (AVTR) NEW YORK STOCK EXCHANGE INC.
$25.21 0.10 (0.40%)
Market Cap: $17.12B
As of 05/15/24 04:00 PM EDT. Market closed.
Avantor Inc.. (AVTR)
NEW YORK STOCK EXCHANGE INC.
$25.21
0.10 (0.40%)
Market Cap: $17.12B
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical ... read more
COMPANY PROFILE
Sector
Industry
PRICE CHART FOR AVANTOR INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$25.45
Previous Close
$25.11
Days Range
$24.68 - $25.48
52 week range
$16.63 - $26.11
Volume
4,525,261
Avg. Volume (30 days)
5,390,431
Market Cap
$17.12B
Dividend Yield
-
P/E
65.86
Shares Outstanding
679,266,323
Open
$25.45
Previous Close
$25.11
Days Range
$24.68 - $25.48
52 week range
$16.63 - $26.11
Volume
4,525,261
Avg. Volume (30 days)
5,390,431
Market Cap
$17.12B
Dividend Yield
-
P/E
65.86
Shares Outstanding
679,266,323
FINANCIAL STATEMENTS FOR AVANTOR INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AVANTOR INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Stone Randy Lee | EVP, Laboratory Solutions | Apr 16, 2024 | Option Exercise | $24.60 | 6,762 | 166,345 | 68,105 | Apr 18, 2024, 05:10 PM |
| Couturier Christophe | EVP, AMEA | Apr 05, 2024 | Option Exercise | $25.87 | 569 | 14,720 | 83,320 | Apr 08, 2024, 05:05 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Mar 08, 2024 | Sale | $25.63 | 3,685 | 94,447 | 34,406 | Mar 12, 2024, 04:46 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 29, 2024 | Sale | $24.52 | 4,910 | 120,393 | 96,233 | Mar 01, 2024, 04:46 PM |
| Couturier Christophe | EVP, AMEA | Feb 29, 2024 | Sale | $24.53 | 13,074 | 320,705 | 83,889 | Mar 01, 2024, 04:42 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 27, 2024 | Sale | $24.49 | 6,203 | 151,911 | 101,143 | Feb 27, 2024, 05:02 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 25, 2024 | Option Exercise | $24.35 | 505 | 12,297 | 26,387 | Feb 26, 2024, 06:57 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 24, 2024 | Option Exercise | $24.35 | 438 | 10,665 | 26,892 | Feb 26, 2024, 06:57 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 23, 2024 | Option Exercise | $24.35 | 422 | 10,276 | 27,330 | Feb 26, 2024, 06:57 PM |
| Stubblefield Michael | President & CEO | Feb 24, 2024 | Option Exercise | $24.35 | 9,595 | 233,638 | 1,119,436 | Feb 26, 2024, 06:56 PM |
| Stubblefield Michael | President & CEO | Feb 23, 2024 | Option Exercise | $24.35 | 7,422 | 180,726 | 1,129,031 | Feb 26, 2024, 06:56 PM |
| Stubblefield Michael | President & CEO | Feb 22, 2024 | Option Exercise | $24.59 | 41,177 | 1,012,542 | 1,136,453 | Feb 26, 2024, 06:56 PM |
| Stubblefield Michael | President & CEO | Feb 25, 2024 | Option Exercise | $24.35 | 7,685 | 187,130 | 1,111,751 | Feb 26, 2024, 06:56 PM |
| Sahin Kitty | EVP, Strategy&Corp Development | Feb 24, 2024 | Option Exercise | $24.35 | 1,059 | 25,787 | 33,885 | Feb 26, 2024, 06:56 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 25, 2024 | Option Exercise | $24.35 | 369 | 8,985 | 23,673 | Feb 26, 2024, 06:56 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 24, 2024 | Option Exercise | $24.35 | 437 | 10,641 | 24,042 | Feb 26, 2024, 06:56 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 23, 2024 | Option Exercise | $24.35 | 421 | 10,251 | 24,479 | Feb 26, 2024, 06:56 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 25, 2024 | Option Exercise | $24.35 | 511 | 12,443 | 86,813 | Feb 26, 2024, 06:55 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 24, 2024 | Option Exercise | $24.35 | 1,955 | 47,604 | 87,324 | Feb 26, 2024, 06:55 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 23, 2024 | Option Exercise | $24.35 | 569 | 13,855 | 89,279 | Feb 26, 2024, 06:55 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 22, 2024 | Option Exercise | $24.59 | 2,842 | 69,885 | 89,848 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 22, 2024 | Option Exercise | $24.59 | 2,574 | 63,295 | 89,254 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 25, 2024 | Option Exercise | $24.35 | 467 | 11,371 | 87,723 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 24, 2024 | Option Exercise | $24.35 | 648 | 15,779 | 88,190 | Feb 26, 2024, 06:55 PM |
| Couturier Christophe | EVP, AMEA | Feb 23, 2024 | Option Exercise | $24.35 | 416 | 10,130 | 88,838 | Feb 26, 2024, 06:55 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Feb 20, 2024 | Option Exercise | $24.05 | 289 | 6,950 | 24,900 | Feb 22, 2024, 05:04 PM |
| Bramwell James | EVP Sales, Customer Excellence | Feb 20, 2024 | Option Exercise | $24.05 | 1,216 | 29,245 | 85,258 | Feb 22, 2024, 05:04 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 20, 2024 | Option Exercise | $24.05 | 435 | 10,462 | 27,752 | Feb 22, 2024, 05:03 PM |
| Stubblefield Michael | President & CEO | Feb 20, 2024 | Option Exercise | $24.05 | 9,711 | 233,550 | 1,078,555 | Feb 22, 2024, 05:03 PM |
| Couturier Christophe | EVP, AMEA | Feb 20, 2024 | Option Exercise | $24.05 | 1,392 | 33,478 | 82,538 | Feb 22, 2024, 05:02 PM |
| Sahin Kitty | EVP, Strategy&Corp Development | Jul 18, 2023 | Option Exercise | $21.01 | 3,931 | 82,590 | 34,944 | Nov 29, 2023, 06:11 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Sep 07, 2023 | Sale | $20.64 | 7,577 | 156,389 | 28,187 | Sep 07, 2023, 05:01 PM |
| Hankamer Brittany | EVP, Chief HR Officer | Sep 05, 2023 | Option Exercise | $21.70 | 309 | 6,705 | 25,189 | Sep 05, 2023, 04:58 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | Aug 25, 2023 | Sale | $21.47 | 25,000 | 536,750 | 160,735 | Aug 28, 2023, 04:10 PM |
| Couturier Christophe | EVP, AMEA | May 17, 2023 | Option Exercise | $20.28 | 15,706 | 318,518 | 82,944 | May 19, 2023, 04:20 PM |
| Miller Justin | EVP & General Counsel | May 17, 2023 | Option Exercise | $20.28 | 12,449 | 252,466 | 93,336 | May 19, 2023, 04:20 PM |
| Stubblefield Michael | President & CEO | May 17, 2023 | Option Exercise | $20.28 | 106,200 | 2,153,736 | 1,172,937 | May 19, 2023, 04:20 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2023 | Option Exercise | $20.28 | 19,683 | 399,171 | 89,032 | May 19, 2023, 04:19 PM |
| Eck Steven W | SVP & Chief Accounting Officer | May 17, 2023 | Option Exercise | $20.28 | 553 | 11,215 | 21,180 | May 19, 2023, 04:19 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | May 17, 2023 | Option Exercise | $20.28 | 2,210 | 44,819 | 185,735 | May 19, 2023, 04:18 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2023 | Option Exercise | $20.28 | 23,261 | 471,733 | 77,489 | May 19, 2023, 04:18 PM |
| Bramwell James | EVP, Strategic Partners | May 17, 2023 | Option Exercise | $20.28 | 18,917 | 383,637 | 85,393 | May 19, 2023, 04:17 PM |
| Couturier Christophe | EVP, AMEA | Apr 11, 2023 | Sale | $21.18 | 1,498 | 31,728 | 98,650 | Apr 13, 2023, 05:03 PM |
| Couturier Christophe | EVP, AMEA | Apr 05, 2023 | Option Exercise | $20.82 | 569 | 11,847 | 100,148 | Apr 06, 2023, 04:38 PM |
| Brophy Gerard | EVP, Biopharma Production | Mar 03, 2023 | Sale | $25.00 | 3,914 | 97,850 | 108,715 | Mar 06, 2023, 04:38 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 27, 2023 | Sale | $25.00 | 3,059 | 76,475 | 112,629 | Mar 01, 2023, 04:46 PM |
| Couturier Christophe | EVP, AMEA | Feb 28, 2023 | Sale | $24.32 | 2,324 | 56,520 | 100,717 | Mar 01, 2023, 04:44 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 25, 2023 | Option Exercise | $24.62 | 2,040 | 50,225 | 115,688 | Feb 27, 2023, 08:10 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 23, 2023 | Option Exercise | $24.59 | 1,893 | 46,549 | 97,420 | Feb 27, 2023, 08:10 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 25, 2023 | Option Exercise | $24.62 | 505 | 12,433 | 21,733 | Feb 27, 2023, 08:09 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 23, 2023 | Option Exercise | $24.59 | 421 | 10,352 | 16,891 | Feb 27, 2023, 08:09 PM |
| Szlosek Thomas A | EVP & CFO | Feb 25, 2023 | Option Exercise | $24.62 | 2,040 | 50,225 | 104,853 | Feb 27, 2023, 08:09 PM |
| Szlosek Thomas A | EVP & CFO | Feb 23, 2023 | Option Exercise | $24.59 | 2,082 | 51,196 | 88,790 | Feb 27, 2023, 08:09 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | Feb 25, 2023 | Option Exercise | $24.62 | 299 | 7,361 | 187,945 | Feb 27, 2023, 08:09 PM |
| Vanderhaegen Frederic | EVP, Americas and Europe | Feb 23, 2023 | Option Exercise | $24.59 | 213 | 5,238 | 167,936 | Feb 27, 2023, 08:09 PM |
| Couturier Christophe | EVP, AMEA | Feb 25, 2023 | Option Exercise | $24.62 | 467 | 11,498 | 103,041 | Feb 27, 2023, 08:08 PM |
| Couturier Christophe | EVP, AMEA | Feb 23, 2023 | Option Exercise | $24.59 | 416 | 10,229 | 97,448 | Feb 27, 2023, 08:08 PM |
| Couturier Christophe | EVP, AMEA | Feb 23, 2023 | Sale | $24.24 | 3,078 | 74,611 | 94,370 | Feb 27, 2023, 08:08 PM |
| Henson Meghan | EVP, Chief HR Officer | Feb 25, 2023 | Option Exercise | $24.62 | 800 | 19,696 | 40,184 | Feb 27, 2023, 08:07 PM |
| Henson Meghan | EVP, Chief HR Officer | Feb 23, 2023 | Option Exercise | $24.59 | 816 | 20,065 | 28,799 | Feb 27, 2023, 08:07 PM |
| Bramwell James | EVP, Americas | Feb 25, 2023 | Option Exercise | $24.62 | 511 | 12,581 | 104,310 | Feb 27, 2023, 08:07 PM |
| Bramwell James | EVP, Americas | Feb 23, 2023 | Option Exercise | $24.59 | 569 | 13,992 | 84,513 | Feb 27, 2023, 08:07 PM |
| Miller Justin | EVP & General Counsel | Feb 25, 2023 | Option Exercise | $24.62 | 560 | 13,787 | 105,785 | Feb 27, 2023, 08:06 PM |
| Miller Justin | EVP & General Counsel | Feb 23, 2023 | Option Exercise | $24.59 | 468 | 11,508 | 97,207 | Feb 27, 2023, 08:06 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Feb 25, 2023 | Option Exercise | $24.62 | 1,340 | 32,991 | 75,248 | Feb 27, 2023, 08:05 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Feb 23, 2023 | Option Exercise | $24.59 | 970 | 23,852 | 64,403 | Feb 27, 2023, 08:05 PM |
| Stubblefield Michael | President & CEO | Feb 25, 2023 | Option Exercise | $24.62 | 7,685 | 189,205 | 1,279,137 | Feb 27, 2023, 08:05 PM |
| Stubblefield Michael | President & CEO | Feb 23, 2023 | Option Exercise | $24.59 | 7,422 | 182,507 | 1,187,818 | Feb 27, 2023, 08:05 PM |
| Szlosek Thomas A | EVP & CFO | Feb 20, 2023 | Option Exercise | $24.54 | 4,253 | 104,369 | 90,872 | Feb 22, 2023, 05:01 PM |
| Couturier Christophe | EVP, AMEA | Feb 20, 2023 | Option Exercise | $24.54 | 1,167 | 28,638 | 117,024 | Feb 22, 2023, 05:01 PM |
| Couturier Christophe | EVP, AMEA | Feb 22, 2023 | Sale | $24.12 | 19,160 | 462,139 | 97,160 | Feb 22, 2023, 05:01 PM |
| Miller Justin | EVP & General Counsel | Feb 20, 2023 | Option Exercise | $24.54 | 1,167 | 28,638 | 97,675 | Feb 22, 2023, 05:00 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 20, 2023 | Option Exercise | $24.54 | 435 | 10,675 | 17,312 | Feb 22, 2023, 04:59 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Feb 20, 2023 | Option Exercise | $24.54 | 398 | 9,767 | 168,149 | Feb 22, 2023, 04:59 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 20, 2023 | Option Exercise | $24.54 | 3,072 | 75,387 | 99,313 | Feb 22, 2023, 04:58 PM |
| Bramwell James | EVP, Americas | Feb 20, 2023 | Option Exercise | $24.54 | 1,066 | 26,160 | 85,082 | Feb 22, 2023, 04:58 PM |
| Stubblefield Michael | President & CEO | Feb 20, 2023 | Option Exercise | $24.54 | 15,026 | 368,738 | 1,195,240 | Feb 22, 2023, 04:57 PM |
| Wondrasch Michael | EVP & CIO | Feb 20, 2023 | Option Exercise | $24.54 | 1,356 | 33,276 | 96,072 | Feb 22, 2023, 04:57 PM |
| Couturier Christophe | EVP, AMEA | Jan 31, 2023 | Option Exercise | $23.90 | 7,658 | 183,026 | 118,191 | Feb 02, 2023, 08:26 PM |
| Stubblefield Michael | CEO | Jan 31, 2023 | Option Exercise | $23.90 | 91,140 | 2,178,246 | 1,210,266 | Feb 02, 2023, 08:26 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 31, 2023 | Option Exercise | $23.90 | 15,221 | 363,782 | 113,724 | Feb 02, 2023, 08:25 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 02, 2023 | Sale | $25.06 | 11,339 | 284,155 | 102,385 | Feb 02, 2023, 08:25 PM |
| Miller Justin | EVP & General Counsel | Jan 31, 2023 | Option Exercise | $23.90 | 7,942 | 189,814 | 98,842 | Feb 02, 2023, 08:25 PM |
| Szlosek Thomas A | EVP & CFO | Jan 31, 2023 | Option Exercise | $23.90 | 24,187 | 578,069 | 124,574 | Feb 02, 2023, 08:25 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Jan 31, 2023 | Option Exercise | $23.90 | 2,515 | 60,108 | 168,547 | Feb 02, 2023, 08:24 PM |
| Henson Meghan | EVP, Chief HR Officer | Dec 31, 2022 | Option Exercise | $21.09 | 1,790 | 37,751 | 29,615 | Jan 04, 2023, 04:59 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Dec 31, 2022 | Option Exercise | $21.09 | 6,075 | 128,122 | 65,373 | Jan 04, 2023, 04:59 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 02, 2023 | Option Exercise | $21.09 | 6,727 | 141,872 | 90,208 | Jan 04, 2023, 04:58 PM |
| Szlosek Thomas A | EVP & CFO | Jan 02, 2023 | Option Exercise | $21.09 | 8,313 | 175,321 | 109,395 | Jan 04, 2023, 04:57 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Jan 02, 2023 | Option Exercise | $21.09 | 1,017 | 21,449 | 126,363 | Jan 04, 2023, 04:57 PM |
| Szlosek Thomas A | EVP & CFO | Nov 16, 2022 | Buy | $20.71 | 12,500 | 258,850 | 35,668 | Nov 17, 2022, 04:42 PM |
| Stubblefield Michael | CEO | Nov 16, 2022 | Buy | $20.95 | 15,000 | 314,250 | 429,500 | Nov 17, 2022, 04:42 PM |
| Brophy Gerard | EVP, Biopharma Production | May 20, 2022 | Sale | $31.27 | 19,603 | 612,986 | 96,935 | May 23, 2022, 04:46 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | May 23, 2022 | Sale | $31.61 | 39,000 | 1,232,790 | 126,764 | May 23, 2022, 04:45 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | May 17, 2022 | Option Exercise | $31.33 | 2,210 | 69,239 | 165,764 | May 19, 2022, 04:15 PM |
| Eck Steven W | SVP & Chief Accounting Officer | May 17, 2022 | Option Exercise | $31.33 | 573 | 17,952 | 17,747 | May 19, 2022, 04:14 PM |
| Miller Justin | EVP & General Counsel | May 17, 2022 | Option Exercise | $31.33 | 12,935 | 405,254 | 79,312 | May 19, 2022, 04:14 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2022 | Option Exercise | $31.33 | 23,261 | 728,767 | 140,260 | May 19, 2022, 04:14 PM |
| Couturier Christophe | EVP, AMEA | May 17, 2022 | Option Exercise | $31.33 | 16,212 | 507,922 | 98,348 | May 19, 2022, 04:14 PM |
| Stubblefield Michael | President and CEO | May 17, 2022 | Option Exercise | $31.33 | 108,700 | 3,405,571 | 1,189,841 | May 19, 2022, 04:13 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2022 | Option Exercise | $31.33 | 19,683 | 616,668 | 116,538 | May 19, 2022, 04:13 PM |
| Couturier Christophe | EVP, AMEA | Apr 05, 2022 | Option Exercise | $31.62 | 568 | 17,960 | 114,560 | Apr 07, 2022, 05:47 PM |
| Brophy Gerard | EVP, Biopharma Production | Mar 01, 2022 | Sale | $34.47 | 2,027 | 69,871 | 136,221 | Mar 02, 2022, 05:07 PM |
| Vanderhaegen Frederic | EVP, Americas & Europe | Feb 25, 2022 | Option Exercise | $35.39 | 216 | 7,644 | 167,974 | Feb 25, 2022, 09:36 PM |
| Szlosek Thomas A | EVP & CFO | Feb 25, 2022 | Option Exercise | $35.39 | 2,043 | 72,302 | 252,746 | Feb 25, 2022, 09:34 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 25, 2022 | Option Exercise | $35.39 | 2,043 | 72,302 | 138,248 | Feb 25, 2022, 09:32 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 23, 2022 | Sale | $33.79 | 3,059 | 103,364 | 125,181 | Feb 25, 2022, 09:32 PM |
| Couturier Christophe | EVP, AMEA | Feb 25, 2022 | Option Exercise | $35.39 | 467 | 16,527 | 115,128 | Feb 25, 2022, 09:27 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 25, 2022 | Option Exercise | $35.39 | 518 | 18,332 | 18,320 | Feb 25, 2022, 09:25 PM |
| Henson Meghan | EVP, Chief HR Officer | Feb 25, 2022 | Option Exercise | $35.39 | 931 | 32,948 | 31,405 | Feb 25, 2022, 09:22 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Feb 25, 2022 | Option Exercise | $35.39 | 1,137 | 40,238 | 71,448 | Feb 25, 2022, 09:19 PM |
| Miller Justin | EVP & General Counsel | Feb 25, 2022 | Option Exercise | $35.39 | 583 | 20,632 | 92,247 | Feb 25, 2022, 09:16 PM |
| Stubblefield Michael | CEO | Feb 25, 2022 | Option Exercise | $35.39 | 7,866 | 278,378 | 1,313,041 | Feb 25, 2022, 09:11 PM |
| Miller Justin | EVP & General Counsel | Feb 20, 2022 | Option Exercise | $34.00 | 1,328 | 45,152 | 86,030 | Feb 22, 2022, 05:29 PM |
| Szlosek Thomas A | EVP & CFO | Feb 20, 2022 | Option Exercise | $34.00 | 4,040 | 137,360 | 238,168 | Feb 22, 2022, 05:29 PM |
| Couturier Christophe | EVP, AMEA | Feb 20, 2022 | Option Exercise | $34.00 | 1,267 | 43,078 | 109,551 | Feb 22, 2022, 05:28 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 20, 2022 | Option Exercise | $34.00 | 3,072 | 104,448 | 128,240 | Feb 22, 2022, 05:27 PM |
| Stubblefield Michael | President and CEO | Feb 20, 2022 | Option Exercise | $34.00 | 10,959 | 372,606 | 1,251,022 | Feb 22, 2022, 05:27 PM |
| Vanderhaegen Frederic | EVP, Europe | Feb 20, 2022 | Option Exercise | $28.69 | 398 | 11,419 | 153,080 | Feb 22, 2022, 05:26 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 20, 2022 | Option Exercise | $34.00 | 448 | 15,232 | 13,700 | Feb 22, 2022, 05:26 PM |
| Murray Mark Christopher | EVP, Biomaterials & AT | Jan 13, 2022 | Option Exercise | $37.50 | 918 | 34,425 | 18,680 | Jan 18, 2022, 05:12 PM |
| Henson Meghan | EVP, Chief HR Officer | Dec 31, 2021 | Option Exercise | $42.14 | 1,877 | 79,097 | 24,025 | Jan 03, 2022, 04:24 PM |
| Lewis Sheri | EVP, Global Ops & Supply Chain | Dec 31, 2021 | Option Exercise | $42.14 | 4,093 | 172,479 | 62,763 | Jan 03, 2022, 04:21 PM |
| Couturier Christophe | EVP, AMEA | Dec 27, 2021 | Option Exercise | $23.21 | 10,184 | 236,371 | 120,681 | Dec 28, 2021, 04:56 PM |
| Couturier Christophe | EVP, AMEA | Dec 27, 2021 | Sale | $41.63 | 10,184 | 423,960 | 110,497 | Dec 28, 2021, 04:56 PM |
| Couturier Christophe | EVP, AMEA | Dec 21, 2021 | Option Exercise | $23.21 | 38,309 | 889,152 | 148,806 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 22, 2021 | Option Exercise | $23.21 | 28,125 | 652,781 | 138,622 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 21, 2021 | Sale | $41.00 | 38,309 | 1,570,669 | 110,497 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 22, 2021 | Sale | $41.53 | 28,125 | 1,168,031 | 110,497 | Dec 23, 2021, 04:28 PM |
| Couturier Christophe | EVP, AMEA | Dec 09, 2021 | Option Exercise | $17.67 | 7,859 | 138,869 | 118,356 | Dec 10, 2021, 05:00 PM |
| Couturier Christophe | EVP, AMEA | Dec 08, 2021 | Option Exercise | $17.67 | 5,828 | 102,981 | 116,325 | Dec 10, 2021, 05:00 PM |
| Couturier Christophe | EVP, AMEA | Dec 09, 2021 | Sale | $40.24 | 7,859 | 316,246 | 110,497 | Dec 10, 2021, 05:00 PM |
| Couturier Christophe | EVP, AMEA | Dec 08, 2021 | Sale | $40.00 | 5,828 | 233,120 | 110,497 | Dec 10, 2021, 05:00 PM |
| GUPTA RAJIV | Director | Dec 01, 2021 | Sale | $39.30 | 100,000 | 3,930,000 | 879,347 | Dec 03, 2021, 08:31 AM |
| Vanderhaegen Frederic | EVP, Europe | Nov 12, 2021 | Option Exercise | $23.20 | 80,000 | 1,856,000 | 234,495 | Nov 15, 2021, 05:33 PM |
| Vanderhaegen Frederic | EVP, Europe | Nov 12, 2021 | Sale | $38.25 | 80,000 | 3,060,000 | 154,495 | Nov 15, 2021, 05:33 PM |
| Vanderhaegen Frederic | EVP, Europe | Nov 11, 2021 | Sale | $38.41 | 60,804 | 2,335,482 | 154,495 | Nov 15, 2021, 05:33 PM |
| GUPTA RAJIV | Director | Nov 01, 2021 | Sale | $40.31 | 100,000 | 4,031,000 | 979,347 | Nov 02, 2021, 08:24 PM |
| GUPTA RAJIV | Director | Oct 01, 2021 | Sale | $39.94 | 100,000 | 3,994,000 | 1,079,347 | Oct 04, 2021, 05:28 PM |
| Stubblefield Michael | President and CEO | Sep 20, 2021 | Sale | $42.37 | 141,300 | 5,986,881 | 1,261,981 | Sep 22, 2021, 05:16 PM |
| GUPTA RAJIV | Director | Sep 01, 2021 | Sale | $39.45 | 100,000 | 3,945,000 | 1,179,347 | Sep 02, 2021, 05:55 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Aug 26, 2021 | Sale | $40.08 | 17,383 | 696,711 | 14,148 | Aug 27, 2021, 04:18 PM |
| GUPTA RAJIV | Director | Aug 20, 2021 | Sale | $38.81 | 100,000 | 3,881,000 | 1,279,347 | Aug 23, 2021, 05:26 PM |
| Natauri Jo | Director | Jul 12, 2021 | Buy | $36.33 | 300 | 10,900 | 557,656 | Aug 13, 2021, 05:10 PM |
| Brophy Gerard | EVP, Biopharma Production | Jul 30, 2021 | Option Exercise | $23.20 | 81,125 | 1,882,100 | 230,504 | Aug 02, 2021, 04:42 PM |
| Brophy Gerard | EVP, Biopharma Production | Jul 30, 2021 | Sale | $37.24 | 81,125 | 3,021,095 | 149,379 | Aug 02, 2021, 04:42 PM |
| Bramwell James | EVP, Strategic Partners | Jul 20, 2021 | Sale | $37.00 | 6,112 | 226,144 | 79,899 | Jul 21, 2021, 05:04 PM |
| Bramwell James | EVP, Strategic Partners | Jul 09, 2021 | Sale | $35.61 | 18,331 | 652,828 | 98,232 | Jul 13, 2021, 05:32 PM |
| GUPTA RAJIV | Director | Jun 25, 2021 | Sale | $35.32 | 68,605 | 2,423,129 | 1,379,347 | Jun 28, 2021, 04:55 PM |
| Ohri Devashish | EVP, IMEA | May 24, 2021 | Option Exercise | $17.67 | 9,124 | 161,221 | 148,219 | May 25, 2021, 05:08 PM |
| Ohri Devashish | EVP, IMEA | May 24, 2021 | Sale | $31.75 | 9,124 | 289,687 | 139,095 | May 25, 2021, 05:08 PM |
| Miller Justin | EVP & General Counsel | May 20, 2021 | Sale | $31.12 | 18,488 | 575,347 | 86,536 | May 21, 2021, 04:55 PM |
| Couturier Christophe | EVP, AMEA | May 20, 2021 | Sale | $31.13 | 25,010 | 778,561 | 138,173 | May 21, 2021, 04:55 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2021 | Option Exercise | $30.90 | 19,683 | 608,205 | 168,982 | May 19, 2021, 05:17 PM |
| Vanderhaegen Frederic | EVP, Europe | May 17, 2021 | Option Exercise | $30.90 | 2,210 | 68,289 | 214,384 | May 19, 2021, 05:16 PM |
| Bramwell James | EVP, Strategic Partners | May 17, 2021 | Option Exercise | $30.90 | 14,324 | 442,612 | 103,812 | May 19, 2021, 05:16 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2021 | Option Exercise | $30.90 | 23,261 | 718,765 | 249,394 | May 19, 2021, 05:16 PM |
| Wondrasch Michael | EVP & CIO | May 17, 2021 | Option Exercise | $30.90 | 13,655 | 421,939 | 131,783 | May 19, 2021, 05:15 PM |
| Natauri Jo | Director | May 11, 2021 | Option Exercise | $30.86 | 92,661 | 2,859,519 | 92,661 | May 13, 2021, 05:47 PM |
| Natauri Jo | Director | May 11, 2021 | Option Exercise | $30.86 | 24,729,495 | 763,152,231 | 175,625 | May 13, 2021, 05:47 PM |
| Natauri Jo | Director | May 11, 2021 | Sale | $30.68 | 2,626,771 | 80,589,335 | 24,807,518 | May 13, 2021, 05:47 PM |
| Ohri Devashish | EVP, IMEA | Apr 12, 2021 | Option Exercise | $1.60 | 100,160 | 160,256 | 256,048 | Apr 13, 2021, 06:03 PM |
| Ohri Devashish | EVP, IMEA | Apr 12, 2021 | Sale | $32.37 | 100,160 | 3,242,179 | 155,888 | Apr 13, 2021, 06:03 PM |
| Vanderhaegen Frederic | EVP, Europe | Apr 12, 2021 | Sale | $31.80 | 27,075 | 860,997 | 233,669 | Apr 13, 2021, 06:03 PM |
| Bramwell James | EVP, Strategic Partners | Apr 12, 2021 | Sale | $32.00 | 2,505 | 80,160 | 118,136 | Apr 13, 2021, 06:02 PM |
| Miller Justin | EVP & General Counsel | Apr 12, 2021 | Option Exercise | $23.21 | 100,000 | 2,321,000 | 218,679 | Apr 13, 2021, 06:02 PM |
| Miller Justin | EVP & General Counsel | Apr 12, 2021 | Sale | $33.17 | 102,895 | 3,412,916 | 118,679 | Apr 13, 2021, 06:02 PM |
| Vanderhaegen Frederic | EVP, Europe | Mar 09, 2021 | Sale | $28.21 | 10,000 | 282,100 | 243,669 | Mar 10, 2021, 05:08 PM |
| Wondrasch Michael | EVP & CIO | Mar 02, 2021 | Sale | $28.71 | 3,036 | 87,164 | 145,438 | Mar 03, 2021, 05:11 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 24, 2021 | Option Exercise | $27.94 | 2,577 | 72,001 | 25,955 | Feb 26, 2021, 06:44 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 24, 2021 | Sale | $27.93 | 3,059 | 85,438 | 172,384 | Feb 26, 2021, 06:34 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 22, 2021 | Option Exercise | $28.69 | 3,072 | 88,136 | 175,443 | Feb 23, 2021, 05:51 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 22, 2021 | Option Exercise | $17.67 | 19,769 | 349,318 | 195,212 | Feb 23, 2021, 05:51 PM |
| Brophy Gerard | EVP, Biopharma Production | Feb 22, 2021 | Sale | $28.62 | 19,769 | 565,789 | 175,443 | Feb 23, 2021, 05:51 PM |
| Couturier Christophe | EVP, Services | Feb 22, 2021 | Option Exercise | $28.69 | 1,313 | 37,670 | 162,408 | Feb 23, 2021, 05:50 PM |
| Wondrasch Michael | EVP & CIO | Feb 22, 2021 | Option Exercise | $28.69 | 1,209 | 34,686 | 140,334 | Feb 23, 2021, 05:47 PM |
| Miller Justin | EVP & General Counsel | Feb 22, 2021 | Option Exercise | $28.69 | 1,350 | 38,732 | 113,434 | Feb 23, 2021, 05:46 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Feb 22, 2021 | Option Exercise | $28.69 | 449 | 12,882 | 19,982 | Feb 23, 2021, 05:44 PM |
| Vanderhaegen Frederic | EVP, Europe | Feb 22, 2021 | Option Exercise | $28.69 | 398 | 11,419 | 237,388 | Feb 23, 2021, 05:43 PM |
| Stubblefield Michael | President and CEO | Feb 22, 2021 | Option Exercise | $28.69 | 10,141 | 290,945 | 1,437,122 | Feb 23, 2021, 05:42 PM |
| Bramwell James | EVP, Strategic Partners | Feb 22, 2021 | Option Exercise | $28.69 | 1,216 | 34,887 | 115,214 | Feb 23, 2021, 05:41 PM |
| Ohri Devashish | EVP, IMEA | Feb 22, 2021 | Option Exercise | $28.69 | 1,210 | 34,715 | 150,461 | Feb 23, 2021, 05:39 PM |
| Szlosek Thomas A | EVP & CFO | Feb 22, 2021 | Option Exercise | $28.69 | 2,980 | 85,496 | 256,374 | Feb 23, 2021, 05:38 PM |
| Wondrasch Michael | EVP & CIO | Feb 05, 2021 | Option Exercise | $23.20 | 40,000 | 928,000 | 181,543 | Feb 08, 2021, 06:23 PM |
| Wondrasch Michael | EVP & CIO | Feb 05, 2021 | Sale | $29.77 | 49,468 | 1,472,662 | 141,543 | Feb 08, 2021, 06:23 PM |
| Murray Mark Christopher | EVP, Biomaterials & AT | Jan 13, 2021 | Option Exercise | $29.20 | 918 | 26,806 | 11,458 | Jan 15, 2021, 05:05 PM |
| Bramwell James | EVP, Strategic Partners | Jan 11, 2021 | Sale | $30.00 | 2,505 | 75,150 | 116,430 | Jan 13, 2021, 05:43 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 11, 2021 | Option Exercise | $23.20 | 378,580 | 8,783,056 | 394,847 | Jan 13, 2021, 05:41 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 11, 2021 | Sale | $30.06 | 378,580 | 11,381,197 | 178,515 | Jan 13, 2021, 05:41 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 06, 2021 | Sale | $27.24 | 11,509 | 313,505 | 178,515 | Jan 08, 2021, 07:31 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 02, 2021 | Option Exercise | $28.15 | 6,559 | 184,636 | 190,024 | Jan 06, 2021, 09:06 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 04, 2021 | Option Exercise | $18.45 | 59,418 | 1,096,262 | 249,442 | Jan 06, 2021, 09:06 PM |
| Brophy Gerard | EVP, Biopharma Production | Jan 04, 2021 | Sale | $27.84 | 59,418 | 1,654,197 | 190,024 | Jan 06, 2021, 09:06 PM |
| Szlosek Thomas A | EVP & CFO | Jan 02, 2021 | Option Exercise | $28.15 | 8,135 | 229,000 | 257,999 | Jan 06, 2021, 09:00 PM |
| Vanderhaegen Frederic | EVP, Europe | Jan 02, 2021 | Option Exercise | $28.15 | 1,017 | 28,629 | 236,414 | Jan 06, 2021, 08:56 PM |
| Wondrasch Michael | EVP & CIO | Jan 02, 2021 | Option Exercise | $28.15 | 4,083 | 114,936 | 149,974 | Jan 06, 2021, 08:53 PM |
| Eck Steven W | SVP & Chief Accounting Officer | Dec 31, 2020 | Option Exercise | $28.15 | 3,052 | 85,914 | 20,431 | Jan 06, 2021, 08:50 PM |
| Bramwell James | EVP, Strategic Partners | Dec 21, 2020 | Sale | $27.14 | 10,020 | 271,943 | 117,768 | Dec 23, 2020, 05:10 PM |
| Shaw Christi | Director | Dec 11, 2020 | Sale | $26.68 | 14,286 | 381,150 | 11,319 | Dec 15, 2020, 07:16 PM |
| Stubblefield Michael | President and CEO | Dec 07, 2020 | Option Exercise | $1.60 | 210,369 | 336,590 | 1,945,717 | Dec 08, 2020, 07:09 PM |
| Stubblefield Michael | President and CEO | Dec 04, 2020 | Option Exercise | $1.60 | 880,601 | 1,408,962 | 2,147,536 | Dec 08, 2020, 07:09 PM |
| Stubblefield Michael | President and CEO | Dec 04, 2020 | Sale | $27.08 | 412,188 | 11,162,051 | 1,735,348 | Dec 08, 2020, 07:09 PM |
| Stubblefield Michael | President and CEO | Dec 07, 2020 | Sale | $27.45 | 98,452 | 2,702,507 | 1,847,265 | Dec 08, 2020, 07:09 PM |
| Natauri Jo | Director | Jun 12, 2020 | Buy | $16.98 | 300 | 5,094 | 58,881,101 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 22, 2020 | Buy | $17.38 | 29 | 504 | 58,881,462 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 26, 2020 | Buy | $16.82 | 20 | 336 | 58,881,228 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 25, 2020 | Buy | $16.84 | 151 | 2,543 | 58,881,889 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 19, 2020 | Buy | $17.95 | 2 | 36 | 58,881,469 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 11, 2020 | Buy | $16.92 | 2,055 | 34,771 | 58,883,032 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jul 01, 2020 | Buy | $16.99 | 1,491 | 25,332 | 58,885,713 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 18, 2020 | Buy | $17.51 | 6,798 | 119,033 | 58,881,461 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 23, 2020 | Buy | $17.75 | 300 | 5,325 | 58,881,711 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 30, 2020 | Buy | $17.09 | 4,053 | 69,270 | 58,885,836 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 22, 2020 | Sale | $17.38 | 29 | 504 | 58,881,433 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 26, 2020 | Sale | $16.82 | 20 | 336 | 58,881,208 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 12, 2020 | Sale | $16.98 | 300 | 5,094 | 58,880,801 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 19, 2020 | Sale | $17.95 | 2 | 36 | 58,881,467 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 11, 2020 | Sale | $16.92 | 2,055 | 34,771 | 58,880,977 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jul 01, 2020 | Sale | $17.05 | 25,410 | 433,156 | 58,875,713 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 25, 2020 | Sale | $16.84 | 151 | 2,543 | 58,881,738 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 23, 2020 | Sale | $17.75 | 300 | 5,325 | 58,881,411 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 30, 2020 | Sale | $17.09 | 4,053 | 69,266 | 58,884,852 | Nov 12, 2020, 07:35 PM |
| Natauri Jo | Director | Jun 18, 2020 | Sale | $17.51 | 6,798 | 119,033 | 58,874,663 | Nov 12, 2020, 07:35 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 23, 2020 | Buy | $17.75 | 300 | 5,325 | 58,881,711 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 30, 2020 | Buy | $17.09 | 4,053 | 69,270 | 58,885,836 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 12, 2020 | Buy | $16.98 | 300 | 5,094 | 58,881,101 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 22, 2020 | Buy | $17.38 | 29 | 504 | 58,881,462 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 26, 2020 | Buy | $16.82 | 20 | 336 | 58,881,228 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 25, 2020 | Buy | $16.84 | 151 | 2,543 | 58,881,889 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 11, 2020 | Buy | $16.92 | 2,055 | 34,771 | 58,883,032 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 19, 2020 | Buy | $17.95 | 2 | 36 | 58,881,469 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jul 01, 2020 | Buy | $16.99 | 1,491 | 25,332 | 58,885,713 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 18, 2020 | Buy | $17.51 | 6,798 | 119,033 | 58,881,461 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 23, 2020 | Sale | $17.75 | 300 | 5,325 | 58,881,411 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 30, 2020 | Sale | $17.09 | 4,053 | 69,266 | 58,884,852 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 18, 2020 | Sale | $17.51 | 6,798 | 119,033 | 58,874,663 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 22, 2020 | Sale | $17.38 | 29 | 504 | 58,881,433 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 26, 2020 | Sale | $16.82 | 20 | 336 | 58,881,208 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 12, 2020 | Sale | $16.98 | 300 | 5,094 | 58,880,801 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 11, 2020 | Sale | $16.92 | 2,055 | 34,771 | 58,880,977 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 19, 2020 | Sale | $17.95 | 2 | 36 | 58,881,467 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jul 01, 2020 | Sale | $17.05 | 25,410 | 433,156 | 58,875,713 | Nov 12, 2020, 07:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 25, 2020 | Sale | $16.84 | 151 | 2,543 | 58,881,738 | Nov 12, 2020, 07:31 PM |
| New Mountain Investments III, LLC | 10% Owner | Nov 10, 2020 | Sale | $24.81 | 36,016,093 | 893,490,828 | 28,000,000 | Nov 10, 2020, 09:24 PM |
| Ohri Devashish | EVP, IMEA | Oct 05, 2020 | Option Exercise | $1.60 | 103,440 | 165,504 | 201,671 | Oct 07, 2020, 08:23 PM |
| Ohri Devashish | EVP, IMEA | Oct 05, 2020 | Sale | $23.42 | 103,440 | 2,422,343 | 151,671 | Oct 07, 2020, 08:23 PM |
| Ohri Devashish | EVP, IMEA | Sep 16, 2020 | Option Exercise | $1.60 | 35,000 | 56,000 | 186,671 | Sep 17, 2020, 04:39 PM |
| Ohri Devashish | EVP, IMEA | Sep 16, 2020 | Sale | $23.02 | 35,000 | 805,700 | 151,671 | Sep 17, 2020, 04:39 PM |
| Miller Justin | EVP & General Counsel | Sep 08, 2020 | Sale | $21.17 | 22,887 | 484,518 | 113,507 | Sep 09, 2020, 04:43 PM |
| Natauri Jo | Director | Aug 21, 2020 | Sale | $19.51 | 15,397,005 | 300,341,682 | 43,483,708 | Aug 25, 2020, 08:46 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Aug 21, 2020 | Sale | $19.51 | 15,397,005 | 300,341,682 | 43,483,708 | Aug 25, 2020, 08:40 PM |
| New Mountain Investments III, LLC | 10% Owner | Aug 21, 2020 | Sale | $19.51 | 25,575,472 | 498,887,951 | 64,016,093 | Aug 25, 2020, 05:08 PM |
| GUPTA RAJIV | Director | Aug 19, 2020 | Option Exercise | $1.60 | 1,147,970 | 1,836,752 | 1,856,716 | Aug 19, 2020, 02:06 PM |
| Ohri Devashish | EVP, IMEA | Jul 30, 2020 | Option Exercise | $1.60 | 35,000 | 56,000 | 186,671 | Aug 03, 2020, 05:45 PM |
| Ohri Devashish | EVP, IMEA | Jul 30, 2020 | Sale | $21.37 | 35,000 | 747,950 | 151,671 | Aug 03, 2020, 05:45 PM |
| Ohri Devashish | EVP, IMEA | May 29, 2020 | Option Exercise | $1.60 | 65,000 | 104,000 | 186,671 | Jun 02, 2020, 05:50 PM |
| Ohri Devashish | EVP, IMEA | May 29, 2020 | Sale | $18.84 | 65,000 | 1,224,550 | 151,671 | Jun 02, 2020, 05:50 PM |
| New Mountain Investments III, LLC | 10% Owner | May 26, 2020 | Sale | $15.90 | 20,886,424 | 332,192,314 | 89,591,565 | May 28, 2020, 06:01 PM |
| Natauri Jo | Director | May 26, 2020 | Sale | $15.90 | 13,726,411 | 218,249,930 | 58,881,710 | May 28, 2020, 05:35 PM |
| Natauri Jo | Director | Jun 13, 2019 | Option Exercise | $0.00 | 1,133,920 | 2,268 | 72,605,349 | May 28, 2020, 05:35 PM |
| Connolly Thomas | Director | May 26, 2020 | Sale | $15.90 | 13,726,411 | 218,249,930 | 58,881,710 | May 28, 2020, 05:31 PM |
| Connolly Thomas | Director | Jun 13, 2019 | Option Exercise | $0.00 | 1,133,920 | 2,268 | 72,605,349 | May 28, 2020, 05:31 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | May 26, 2020 | Sale | $15.90 | 13,726,411 | 218,249,930 | 58,881,710 | May 28, 2020, 05:26 PM |
| GOLDMAN SACHS & CO. LLC | 10% Owner | Jun 13, 2019 | Option Exercise | $0.00 | 1,133,920 | 2,268 | 72,605,349 | May 28, 2020, 05:26 PM |
| Wondrasch Michael | EVP & CIO | May 22, 2020 | Sale | $17.82 | 22,987 | 409,628 | 154,087 | May 27, 2020, 04:26 PM |
| Brophy Gerard | EVP, Biopharma Production | May 20, 2020 | Sale | $17.36 | 25,495 | 442,593 | 196,583 | May 22, 2020, 04:22 PM |
| Szlosek Thomas A | EVP & CFO | May 17, 2020 | Option Exercise | $17.86 | 21,287 | 380,186 | 266,134 | May 19, 2020, 06:58 PM |
| Wondrasch Michael | EVP & CIO | May 17, 2020 | Option Exercise | $17.86 | 9,155 | 163,508 | 177,044 | May 19, 2020, 06:57 PM |
| Brophy Gerard | EVP, Biopharma Production | May 17, 2020 | Option Exercise | $17.86 | 13,790 | 246,289 | 222,078 | May 19, 2020, 06:55 PM |
| Couturier Christophe | EVP, Services | May 17, 2020 | Option Exercise | $17.86 | 11,189 | 199,836 | 162,932 | May 19, 2020, 06:53 PM |
| Vanderhaegen Frederic | EVP, Europe | May 17, 2020 | Option Exercise | $17.86 | 2,210 | 39,471 | 237,431 | May 19, 2020, 06:52 PM |
| Miller Justin | EVP & General Counsel | May 17, 2020 | Option Exercise | $17.86 | 9,155 | 163,508 | 136,394 | May 19, 2020, 06:50 PM |
| Ohri Devashish | EVP, IMEA | May 17, 2020 | Option Exercise | $17.86 | 16,791 | 299,887 | 151,671 | May 19, 2020, 06:48 PM |
| McAllister Eric | EVP, CHRO | May 17, 2020 | Option Exercise | $17.86 | 9,155 | 163,508 | 197,899 | May 19, 2020, 06:47 PM |
| Stubblefield Michael | CEO | May 17, 2020 | Option Exercise | $17.86 | 108,700 | 1,941,382 | 1,266,935 | May 19, 2020, 06:45 PM |
| Bramwell James | EVP, Strategic Partners | May 17, 2020 | Option Exercise | $17.86 | 12,102 | 216,142 | 127,788 | May 19, 2020, 06:44 PM |
| Eck Steven W | SVP & Chief Accounting Officer | May 17, 2020 | Option Exercise | $17.86 | 573 | 10,234 | 23,483 | May 19, 2020, 06:42 PM |
| McAllister Eric | EVP, CHRO | Apr 24, 2020 | Option Exercise | $14.04 | 8,975 | 126,009 | 207,054 | May 12, 2020, 04:34 PM |
| Stubblefield Michael | CEO | Mar 12, 2020 | Option Exercise | $1.60 | 200,000 | 320,000 | 1,375,635 | Mar 13, 2020, 04:32 PM |
| GUPTA RAJIV | Director | Mar 10, 2020 | Option Exercise | $1.60 | 143,000 | 228,800 | 708,746 | Mar 12, 2020, 04:25 PM |
| Ohri Devashish | EVP, IMEA | Feb 18, 2020 | Option Exercise | $1.60 | 20,000 | 32,000 | 177,143 | Feb 20, 2020, 05:32 PM |
| Ohri Devashish | EVP, IMEA | Feb 18, 2020 | Sale | $17.54 | 20,000 | 350,800 | 157,143 | Feb 20, 2020, 05:32 PM |
| New Mountain Investments III, LLC | 10% Owner | May 21, 2019 | Sale | $14.00 | 100 | 1,400 | 110,477,989 | May 23, 2019, 07:31 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Stone Randy Lee | EVP, Laboratory Solutions | 04/16/2024 | 166,345 |
| Couturier Christophe | EVP, AMEA | 04/05/2024 | 14,720 |
| Eck Steven W | SVP & Chief Accounting Officer | 03/08/2024 | 94,447 |
| Bramwell James | EVP Sales, Customer Excellence | 02/29/2024 | 120,393 |
| Couturier Christophe | EVP, AMEA | 02/29/2024 | 320,705 |
| Bramwell James | EVP Sales, Customer Excellence | 02/27/2024 | 151,911 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/25/2024 | 12,297 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/24/2024 | 10,665 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/23/2024 | 10,276 |
| Stubblefield Michael | President & CEO | 02/24/2024 | 233,638 |
| Stubblefield Michael | President & CEO | 02/23/2024 | 180,726 |
| Stubblefield Michael | President & CEO | 02/22/2024 | 1,012,542 |
| Stubblefield Michael | President & CEO | 02/25/2024 | 187,130 |
| Sahin Kitty | EVP, Strategy&Corp Development | 02/24/2024 | 25,787 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/25/2024 | 8,985 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/24/2024 | 10,641 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/23/2024 | 10,251 |
| Bramwell James | EVP Sales, Customer Excellence | 02/25/2024 | 12,443 |
| Bramwell James | EVP Sales, Customer Excellence | 02/24/2024 | 47,604 |
| Bramwell James | EVP Sales, Customer Excellence | 02/23/2024 | 13,855 |
| Bramwell James | EVP Sales, Customer Excellence | 02/22/2024 | 69,885 |
| Couturier Christophe | EVP, AMEA | 02/22/2024 | 63,295 |
| Couturier Christophe | EVP, AMEA | 02/25/2024 | 11,371 |
| Couturier Christophe | EVP, AMEA | 02/24/2024 | 15,779 |
| Couturier Christophe | EVP, AMEA | 02/23/2024 | 10,130 |
| Hankamer Brittany | EVP, Chief HR Officer | 02/20/2024 | 6,950 |
| Bramwell James | EVP Sales, Customer Excellence | 02/20/2024 | 29,245 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/20/2024 | 10,462 |
| Stubblefield Michael | President & CEO | 02/20/2024 | 233,550 |
| Couturier Christophe | EVP, AMEA | 02/20/2024 | 33,478 |
| Sahin Kitty | EVP, Strategy&Corp Development | 07/18/2023 | 82,590 |
| Eck Steven W | SVP & Chief Accounting Officer | 09/07/2023 | 156,389 |
| Hankamer Brittany | EVP, Chief HR Officer | 09/05/2023 | 6,705 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 08/25/2023 | 536,750 |
| Couturier Christophe | EVP, AMEA | 05/17/2023 | 318,518 |
| Miller Justin | EVP & General Counsel | 05/17/2023 | 252,466 |
| Stubblefield Michael | President & CEO | 05/17/2023 | 2,153,736 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2023 | 399,171 |
| Eck Steven W | SVP & Chief Accounting Officer | 05/17/2023 | 11,215 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 05/17/2023 | 44,819 |
| Szlosek Thomas A | EVP & CFO | 05/17/2023 | 471,733 |
| Bramwell James | EVP, Strategic Partners | 05/17/2023 | 383,637 |
| Couturier Christophe | EVP, AMEA | 04/11/2023 | 31,728 |
| Couturier Christophe | EVP, AMEA | 04/05/2023 | 11,847 |
| Brophy Gerard | EVP, Biopharma Production | 03/03/2023 | 97,850 |
| Brophy Gerard | EVP, Biopharma Production | 02/27/2023 | 76,475 |
| Couturier Christophe | EVP, AMEA | 02/28/2023 | 56,520 |
| Brophy Gerard | EVP, Biopharma Production | 02/25/2023 | 50,225 |
| Brophy Gerard | EVP, Biopharma Production | 02/23/2023 | 46,549 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/25/2023 | 12,433 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/23/2023 | 10,352 |
| Szlosek Thomas A | EVP & CFO | 02/25/2023 | 50,225 |
| Szlosek Thomas A | EVP & CFO | 02/23/2023 | 51,196 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 02/25/2023 | 7,361 |
| Vanderhaegen Frederic | EVP, Americas and Europe | 02/23/2023 | 5,238 |
| Couturier Christophe | EVP, AMEA | 02/25/2023 | 11,498 |
| Couturier Christophe | EVP, AMEA | 02/23/2023 | 10,229 |
| Couturier Christophe | EVP, AMEA | 02/23/2023 | 74,611 |
| Henson Meghan | EVP, Chief HR Officer | 02/25/2023 | 19,696 |
| Henson Meghan | EVP, Chief HR Officer | 02/23/2023 | 20,065 |
| Bramwell James | EVP, Americas | 02/25/2023 | 12,581 |
| Bramwell James | EVP, Americas | 02/23/2023 | 13,992 |
| Miller Justin | EVP & General Counsel | 02/25/2023 | 13,787 |
| Miller Justin | EVP & General Counsel | 02/23/2023 | 11,508 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 02/25/2023 | 32,991 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 02/23/2023 | 23,852 |
| Stubblefield Michael | President & CEO | 02/25/2023 | 189,205 |
| Stubblefield Michael | President & CEO | 02/23/2023 | 182,507 |
| Szlosek Thomas A | EVP & CFO | 02/20/2023 | 104,369 |
| Couturier Christophe | EVP, AMEA | 02/20/2023 | 28,638 |
| Couturier Christophe | EVP, AMEA | 02/22/2023 | 462,139 |
| Miller Justin | EVP & General Counsel | 02/20/2023 | 28,638 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/20/2023 | 10,675 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 02/20/2023 | 9,767 |
| Brophy Gerard | EVP, Biopharma Production | 02/20/2023 | 75,387 |
| Bramwell James | EVP, Americas | 02/20/2023 | 26,160 |
| Stubblefield Michael | President & CEO | 02/20/2023 | 368,738 |
| Wondrasch Michael | EVP & CIO | 02/20/2023 | 33,276 |
| Couturier Christophe | EVP, AMEA | 01/31/2023 | 183,026 |
| Stubblefield Michael | CEO | 01/31/2023 | 2,178,246 |
| Brophy Gerard | EVP, Biopharma Production | 01/31/2023 | 363,782 |
| Brophy Gerard | EVP, Biopharma Production | 02/02/2023 | 284,155 |
| Miller Justin | EVP & General Counsel | 01/31/2023 | 189,814 |
| Szlosek Thomas A | EVP & CFO | 01/31/2023 | 578,069 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 01/31/2023 | 60,108 |
| Henson Meghan | EVP, Chief HR Officer | 12/31/2022 | 37,751 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 12/31/2022 | 128,122 |
| Brophy Gerard | EVP, Biopharma Production | 01/02/2023 | 141,872 |
| Szlosek Thomas A | EVP & CFO | 01/02/2023 | 175,321 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 01/02/2023 | 21,449 |
| Szlosek Thomas A | EVP & CFO | 11/16/2022 | 258,850 |
| Stubblefield Michael | CEO | 11/16/2022 | 314,250 |
| Brophy Gerard | EVP, Biopharma Production | 05/20/2022 | 612,986 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 05/23/2022 | 1,232,790 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 05/17/2022 | 69,239 |
| Eck Steven W | SVP & Chief Accounting Officer | 05/17/2022 | 17,952 |
| Miller Justin | EVP & General Counsel | 05/17/2022 | 405,254 |
| Szlosek Thomas A | EVP & CFO | 05/17/2022 | 728,767 |
| Couturier Christophe | EVP, AMEA | 05/17/2022 | 507,922 |
| Stubblefield Michael | President and CEO | 05/17/2022 | 3,405,571 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2022 | 616,668 |
| Couturier Christophe | EVP, AMEA | 04/05/2022 | 17,960 |
| Brophy Gerard | EVP, Biopharma Production | 03/01/2022 | 69,871 |
| Vanderhaegen Frederic | EVP, Americas & Europe | 02/25/2022 | 7,644 |
| Szlosek Thomas A | EVP & CFO | 02/25/2022 | 72,302 |
| Brophy Gerard | EVP, Biopharma Production | 02/25/2022 | 72,302 |
| Brophy Gerard | EVP, Biopharma Production | 02/23/2022 | 103,364 |
| Couturier Christophe | EVP, AMEA | 02/25/2022 | 16,527 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/25/2022 | 18,332 |
| Henson Meghan | EVP, Chief HR Officer | 02/25/2022 | 32,948 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 02/25/2022 | 40,238 |
| Miller Justin | EVP & General Counsel | 02/25/2022 | 20,632 |
| Stubblefield Michael | CEO | 02/25/2022 | 278,378 |
| Miller Justin | EVP & General Counsel | 02/20/2022 | 45,152 |
| Szlosek Thomas A | EVP & CFO | 02/20/2022 | 137,360 |
| Couturier Christophe | EVP, AMEA | 02/20/2022 | 43,078 |
| Brophy Gerard | EVP, Biopharma Production | 02/20/2022 | 104,448 |
| Stubblefield Michael | President and CEO | 02/20/2022 | 372,606 |
| Vanderhaegen Frederic | EVP, Europe | 02/20/2022 | 11,419 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/20/2022 | 15,232 |
| Murray Mark Christopher | EVP, Biomaterials & AT | 01/13/2022 | 34,425 |
| Henson Meghan | EVP, Chief HR Officer | 12/31/2021 | 79,097 |
| Lewis Sheri | EVP, Global Ops & Supply Chain | 12/31/2021 | 172,479 |
| Couturier Christophe | EVP, AMEA | 12/27/2021 | 236,371 |
| Couturier Christophe | EVP, AMEA | 12/27/2021 | 423,960 |
| Couturier Christophe | EVP, AMEA | 12/21/2021 | 889,152 |
| Couturier Christophe | EVP, AMEA | 12/22/2021 | 652,781 |
| Couturier Christophe | EVP, AMEA | 12/21/2021 | 1,570,669 |
| Couturier Christophe | EVP, AMEA | 12/22/2021 | 1,168,031 |
| Couturier Christophe | EVP, AMEA | 12/09/2021 | 138,869 |
| Couturier Christophe | EVP, AMEA | 12/08/2021 | 102,981 |
| Couturier Christophe | EVP, AMEA | 12/09/2021 | 316,246 |
| Couturier Christophe | EVP, AMEA | 12/08/2021 | 233,120 |
| GUPTA RAJIV | Director | 12/01/2021 | 3,930,000 |
| Vanderhaegen Frederic | EVP, Europe | 11/12/2021 | 1,856,000 |
| Vanderhaegen Frederic | EVP, Europe | 11/12/2021 | 3,060,000 |
| Vanderhaegen Frederic | EVP, Europe | 11/11/2021 | 2,335,482 |
| GUPTA RAJIV | Director | 11/01/2021 | 4,031,000 |
| GUPTA RAJIV | Director | 10/01/2021 | 3,994,000 |
| Stubblefield Michael | President and CEO | 09/20/2021 | 5,986,881 |
| GUPTA RAJIV | Director | 09/01/2021 | 3,945,000 |
| Eck Steven W | SVP & Chief Accounting Officer | 08/26/2021 | 696,711 |
| GUPTA RAJIV | Director | 08/20/2021 | 3,881,000 |
| Natauri Jo | Director | 07/12/2021 | 10,900 |
| Brophy Gerard | EVP, Biopharma Production | 07/30/2021 | 1,882,100 |
| Brophy Gerard | EVP, Biopharma Production | 07/30/2021 | 3,021,095 |
| Bramwell James | EVP, Strategic Partners | 07/20/2021 | 226,144 |
| Bramwell James | EVP, Strategic Partners | 07/09/2021 | 652,828 |
| GUPTA RAJIV | Director | 06/25/2021 | 2,423,129 |
| Ohri Devashish | EVP, IMEA | 05/24/2021 | 161,221 |
| Ohri Devashish | EVP, IMEA | 05/24/2021 | 289,687 |
| Miller Justin | EVP & General Counsel | 05/20/2021 | 575,347 |
| Couturier Christophe | EVP, AMEA | 05/20/2021 | 778,561 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2021 | 608,205 |
| Vanderhaegen Frederic | EVP, Europe | 05/17/2021 | 68,289 |
| Bramwell James | EVP, Strategic Partners | 05/17/2021 | 442,612 |
| Szlosek Thomas A | EVP & CFO | 05/17/2021 | 718,765 |
| Wondrasch Michael | EVP & CIO | 05/17/2021 | 421,939 |
| Natauri Jo | Director | 05/11/2021 | 2,859,519 |
| Natauri Jo | Director | 05/11/2021 | 763,152,231 |
| Natauri Jo | Director | 05/11/2021 | 80,589,335 |
| Ohri Devashish | EVP, IMEA | 04/12/2021 | 160,256 |
| Ohri Devashish | EVP, IMEA | 04/12/2021 | 3,242,179 |
| Vanderhaegen Frederic | EVP, Europe | 04/12/2021 | 860,997 |
| Bramwell James | EVP, Strategic Partners | 04/12/2021 | 80,160 |
| Miller Justin | EVP & General Counsel | 04/12/2021 | 2,321,000 |
| Miller Justin | EVP & General Counsel | 04/12/2021 | 3,412,916 |
| Vanderhaegen Frederic | EVP, Europe | 03/09/2021 | 282,100 |
| Wondrasch Michael | EVP & CIO | 03/02/2021 | 87,164 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/24/2021 | 72,001 |
| Brophy Gerard | EVP, Biopharma Production | 02/24/2021 | 85,438 |
| Brophy Gerard | EVP, Biopharma Production | 02/22/2021 | 88,136 |
| Brophy Gerard | EVP, Biopharma Production | 02/22/2021 | 349,318 |
| Brophy Gerard | EVP, Biopharma Production | 02/22/2021 | 565,789 |
| Couturier Christophe | EVP, Services | 02/22/2021 | 37,670 |
| Wondrasch Michael | EVP & CIO | 02/22/2021 | 34,686 |
| Miller Justin | EVP & General Counsel | 02/22/2021 | 38,732 |
| Eck Steven W | SVP & Chief Accounting Officer | 02/22/2021 | 12,882 |
| Vanderhaegen Frederic | EVP, Europe | 02/22/2021 | 11,419 |
| Stubblefield Michael | President and CEO | 02/22/2021 | 290,945 |
| Bramwell James | EVP, Strategic Partners | 02/22/2021 | 34,887 |
| Ohri Devashish | EVP, IMEA | 02/22/2021 | 34,715 |
| Szlosek Thomas A | EVP & CFO | 02/22/2021 | 85,496 |
| Wondrasch Michael | EVP & CIO | 02/05/2021 | 928,000 |
| Wondrasch Michael | EVP & CIO | 02/05/2021 | 1,472,662 |
| Murray Mark Christopher | EVP, Biomaterials & AT | 01/13/2021 | 26,806 |
| Bramwell James | EVP, Strategic Partners | 01/11/2021 | 75,150 |
| Brophy Gerard | EVP, Biopharma Production | 01/11/2021 | 8,783,056 |
| Brophy Gerard | EVP, Biopharma Production | 01/11/2021 | 11,381,197 |
| Brophy Gerard | EVP, Biopharma Production | 01/06/2021 | 313,505 |
| Brophy Gerard | EVP, Biopharma Production | 01/02/2021 | 184,636 |
| Brophy Gerard | EVP, Biopharma Production | 01/04/2021 | 1,096,262 |
| Brophy Gerard | EVP, Biopharma Production | 01/04/2021 | 1,654,197 |
| Szlosek Thomas A | EVP & CFO | 01/02/2021 | 229,000 |
| Vanderhaegen Frederic | EVP, Europe | 01/02/2021 | 28,629 |
| Wondrasch Michael | EVP & CIO | 01/02/2021 | 114,936 |
| Eck Steven W | SVP & Chief Accounting Officer | 12/31/2020 | 85,914 |
| Bramwell James | EVP, Strategic Partners | 12/21/2020 | 271,943 |
| Shaw Christi | Director | 12/11/2020 | 381,150 |
| Stubblefield Michael | President and CEO | 12/07/2020 | 336,590 |
| Stubblefield Michael | President and CEO | 12/04/2020 | 1,408,962 |
| Stubblefield Michael | President and CEO | 12/04/2020 | 11,162,051 |
| Stubblefield Michael | President and CEO | 12/07/2020 | 2,702,507 |
| Natauri Jo | Director | 06/12/2020 | 5,094 |
| Natauri Jo | Director | 06/22/2020 | 504 |
| Natauri Jo | Director | 06/26/2020 | 336 |
| Natauri Jo | Director | 06/25/2020 | 2,543 |
| Natauri Jo | Director | 06/19/2020 | 36 |
| Natauri Jo | Director | 06/11/2020 | 34,771 |
| Natauri Jo | Director | 07/01/2020 | 25,332 |
| Natauri Jo | Director | 06/18/2020 | 119,033 |
| Natauri Jo | Director | 06/23/2020 | 5,325 |
| Natauri Jo | Director | 06/30/2020 | 69,270 |
| Natauri Jo | Director | 06/22/2020 | 504 |
| Natauri Jo | Director | 06/26/2020 | 336 |
| Natauri Jo | Director | 06/12/2020 | 5,094 |
| Natauri Jo | Director | 06/19/2020 | 36 |
| Natauri Jo | Director | 06/11/2020 | 34,771 |
| Natauri Jo | Director | 07/01/2020 | 433,156 |
| Natauri Jo | Director | 06/25/2020 | 2,543 |
| Natauri Jo | Director | 06/23/2020 | 5,325 |
| Natauri Jo | Director | 06/30/2020 | 69,266 |
| Natauri Jo | Director | 06/18/2020 | 119,033 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/23/2020 | 5,325 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/30/2020 | 69,270 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/12/2020 | 5,094 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/22/2020 | 504 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/26/2020 | 336 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/25/2020 | 2,543 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/11/2020 | 34,771 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/19/2020 | 36 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 07/01/2020 | 25,332 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/18/2020 | 119,033 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/23/2020 | 5,325 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/30/2020 | 69,266 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/18/2020 | 119,033 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/22/2020 | 504 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/26/2020 | 336 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/12/2020 | 5,094 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/11/2020 | 34,771 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/19/2020 | 36 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 07/01/2020 | 433,156 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/25/2020 | 2,543 |
| New Mountain Investments III, LLC | 10% Owner | 11/10/2020 | 893,490,828 |
| Ohri Devashish | EVP, IMEA | 10/05/2020 | 165,504 |
| Ohri Devashish | EVP, IMEA | 10/05/2020 | 2,422,343 |
| Ohri Devashish | EVP, IMEA | 09/16/2020 | 56,000 |
| Ohri Devashish | EVP, IMEA | 09/16/2020 | 805,700 |
| Miller Justin | EVP & General Counsel | 09/08/2020 | 484,518 |
| Natauri Jo | Director | 08/21/2020 | 300,341,682 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 08/21/2020 | 300,341,682 |
| New Mountain Investments III, LLC | 10% Owner | 08/21/2020 | 498,887,951 |
| GUPTA RAJIV | Director | 08/19/2020 | 1,836,752 |
| Ohri Devashish | EVP, IMEA | 07/30/2020 | 56,000 |
| Ohri Devashish | EVP, IMEA | 07/30/2020 | 747,950 |
| Ohri Devashish | EVP, IMEA | 05/29/2020 | 104,000 |
| Ohri Devashish | EVP, IMEA | 05/29/2020 | 1,224,550 |
| New Mountain Investments III, LLC | 10% Owner | 05/26/2020 | 332,192,314 |
| Natauri Jo | Director | 05/26/2020 | 218,249,930 |
| Natauri Jo | Director | 06/13/2019 | 2,268 |
| Connolly Thomas | Director | 05/26/2020 | 218,249,930 |
| Connolly Thomas | Director | 06/13/2019 | 2,268 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 05/26/2020 | 218,249,930 |
| GOLDMAN SACHS & CO. LLC | 10% Owner | 06/13/2019 | 2,268 |
| Wondrasch Michael | EVP & CIO | 05/22/2020 | 409,628 |
| Brophy Gerard | EVP, Biopharma Production | 05/20/2020 | 442,593 |
| Szlosek Thomas A | EVP & CFO | 05/17/2020 | 380,186 |
| Wondrasch Michael | EVP & CIO | 05/17/2020 | 163,508 |
| Brophy Gerard | EVP, Biopharma Production | 05/17/2020 | 246,289 |
| Couturier Christophe | EVP, Services | 05/17/2020 | 199,836 |
| Vanderhaegen Frederic | EVP, Europe | 05/17/2020 | 39,471 |
| Miller Justin | EVP & General Counsel | 05/17/2020 | 163,508 |
| Ohri Devashish | EVP, IMEA | 05/17/2020 | 299,887 |
| McAllister Eric | EVP, CHRO | 05/17/2020 | 163,508 |
| Stubblefield Michael | CEO | 05/17/2020 | 1,941,382 |
| Bramwell James | EVP, Strategic Partners | 05/17/2020 | 216,142 |
| Eck Steven W | SVP & Chief Accounting Officer | 05/17/2020 | 10,234 |
| McAllister Eric | EVP, CHRO | 04/24/2020 | 126,009 |
| Stubblefield Michael | CEO | 03/12/2020 | 320,000 |
| GUPTA RAJIV | Director | 03/10/2020 | 228,800 |
| Ohri Devashish | EVP, IMEA | 02/18/2020 | 32,000 |
| Ohri Devashish | EVP, IMEA | 02/18/2020 | 350,800 |
| New Mountain Investments III, LLC | 10% Owner | 05/21/2019 | 1,400 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AVANTOR INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| DODGE & COX | 63,680,306 | 0.94% | 4.06% | Value |
| BLACKROCK INC. | 42,761,210 | 0.03% | -6.73% | Other |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | 23,579,307 | 2.03% | -3.22% | Value |
| GEODE CAPITAL MANAGEMENT, LLC | 10,224,631 | 0.02% | 3.77% | Other |
| PARNASSUS INVESTMENTS, LLC | 3,214,576 | 0.18% | -53.67% | Growth At A Reasonable Price |
| HOLOCENE ADVISORS, LP | 3,699,294 | 0.35% | New | Growth At A Reasonable Price |
| BALYASNY ASSET MANAGEMENT L.P. | 2,678,597 | 0.12% | 1646.46% | Event Driven |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 800,100 | 0.04% | -42.85% | Other |
| MAGNETAR FINANCIAL LLC | 1,374,812 | 0.79% | New | Event Driven, Other |
| D. E. SHAW & CO., INC. | 1,031,538 | 0.02% | 633.67% | Other |
| SOROS FUND MANAGEMENT LLC | 500,000 | 0.21% | -37.5% | Other |
| AQR CAPITAL MANAGEMENT LLC | 288,505 | 0.01% | -36.59% | Other |
| GABELLI FUNDS LLC | 425,224 | 0.08% | No change | Event Driven, Growth, Activists |
| OLSTEIN CAPITAL MANAGEMENT, L.P. | 294,184 | 1.23% | -6.61% | Value |
| SAND GROVE CAPITAL MANAGEMENT LLP | 88,000 | 0.53% | Exited | Value |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 71,850 | 0.07% | 87.84% | Growth At A Reasonable Price |
| CANDRIAM S.C.A. | 53,378 | 0.00873% | 20.67% | Other |
| GOTHAM ASSET MANAGEMENT, LLC | 16,568 | 0.0064% | -3.09% | Other |
| FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 15,882 | 0.00092% | No change | Value |
CHANGE IN SHARES OUTSTANDING FOR AVANTOR INC.
STOCK BUYBACKS FOR AVANTOR INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
0.31%
1Q
09/30/2023
0.43%
2Q
06/30/2023
0.90%
3Q
03/31/2023
0.49%
4Q
12/31/2022
0.74%
5Q
09/30/2022
0.31%
6Q
06/30/2022
0.18%
7Q
03/31/2022
0.01%
8Q
12/31/2021
10.01%
9Q
09/30/2021
13.93%
10Q
06/30/2021
15.28%
11Q
03/31/2021
15.67%
12Q
12/31/2020
16.26%
13Q
09/30/2020
18.05%
14Q
06/30/2020
17.06%
15Q
03/31/2020
17.22%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AVANTOR INC.
LOADING...